Search research articles
Contact Us
Filters
Showing results (21-30 of 50) with videos related to
Page
of 5
Sort By:
International Journal of Biological Macromolecules
|
May 2, 2026
LILRB2<sup>+</sup> monocytes reshape the immune activation landscape in immunotherapy with non-small cell lung cancer: Evidence from real-world cohorts and single-cell analyses
Linfeng Luo, Shuhui Dong, Jiahong Yi, et al.
Plos One
|
December 5, 2018
Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data
Guifang Guo, Xiuxing Chen, Wenzhuo He, et al.
Oncotargets and Therapy
|
September 15, 2015
Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer
Qiong Yang, Chenxi Yin, Fangxin Liao, et al.
Oncotarget
|
March 19, 2016
Longterm effects of palliative local treatment of incurable metastatic lesions in colorectal cancer patients
Qiong Yang, Fangxin Liao, Yuanyuan Huang, et al.
BMC Cancer
|
September 29, 2018
Second primary colorectal cancer after the initial primary colorectal cancer
Lin Yang, Zhenchong Xiong, Qian Kun Xie, et al.
Journal of Cancer
|
June 18, 2019
Circulating Lymphocytes, PD-L1 Expression on Tumor-infiltrating Lymphocytes, and Survival of Colorectal Cancer Patients with Different Mismatch Repair Gene Status
Pengfei Kong, Jing Wang, Ze Song, et al.
Journal of Cancer
|
November 22, 2017
Association between Mismatch-repair Genetic variation and the Risk of Multiple Primary Cancers: A Meta-Analysis
Pengfei Kong, Ruiyan Wu, Yadong Lan, et al.
Journal of Cancer
|
October 5, 2016
The Efficacy of Bevacizumab in Different Line Chemotherapy for Chinese Patients with Metastatic Colorectal Cancer
Chenxi Yin, Gang Ma, Yuming Rong, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
February 5, 2024
Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression
Kunwei Peng, Yongxiang Liu, Shousheng Liu, et al.
Journal of Cancer
|
March 12, 2019
Positive impact of the negative lymph node count on the survival rate of stage III colon cancer with pN1 and right-side disease
Qi Quan, Mingshu Zhu, Shousheng Liu, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 50) with videos related to
Sort By:
Page
of 5
International Journal of Biological Macromolecules
|
May 2, 2026
LILRB2<sup>+</sup> monocytes reshape the immune activation landscape in immunotherapy with non-small cell lung cancer: Evidence from real-world cohorts and single-cell analyses
Linfeng Luo, Shuhui Dong, Jiahong Yi, et al.
Plos One
|
December 5, 2018
Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data
Guifang Guo, Xiuxing Chen, Wenzhuo He, et al.
Oncotargets and Therapy
|
September 15, 2015
Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer
Qiong Yang, Chenxi Yin, Fangxin Liao, et al.
Oncotarget
|
March 19, 2016
Longterm effects of palliative local treatment of incurable metastatic lesions in colorectal cancer patients
Qiong Yang, Fangxin Liao, Yuanyuan Huang, et al.
BMC Cancer
|
September 29, 2018
Second primary colorectal cancer after the initial primary colorectal cancer
Lin Yang, Zhenchong Xiong, Qian Kun Xie, et al.
Journal of Cancer
|
June 18, 2019
Circulating Lymphocytes, PD-L1 Expression on Tumor-infiltrating Lymphocytes, and Survival of Colorectal Cancer Patients with Different Mismatch Repair Gene Status
Pengfei Kong, Jing Wang, Ze Song, et al.
Journal of Cancer
|
November 22, 2017
Association between Mismatch-repair Genetic variation and the Risk of Multiple Primary Cancers: A Meta-Analysis
Pengfei Kong, Ruiyan Wu, Yadong Lan, et al.
Journal of Cancer
|
October 5, 2016
The Efficacy of Bevacizumab in Different Line Chemotherapy for Chinese Patients with Metastatic Colorectal Cancer
Chenxi Yin, Gang Ma, Yuming Rong, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
February 5, 2024
Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression
Kunwei Peng, Yongxiang Liu, Shousheng Liu, et al.
Journal of Cancer
|
March 12, 2019
Positive impact of the negative lymph node count on the survival rate of stage III colon cancer with pN1 and right-side disease
Qi Quan, Mingshu Zhu, Shousheng Liu, et al.
Page
of 5